High Intensity Focused Ultrasound for X-linked Dystonia-parkinsonism
Bilateral Transcranial Magnetic Resonance-guided Focused Ultrasound Pallidothalamic Tractotomy for Patients With X-linked Dystonia-parkinsonism
1 other identifier
expanded_access
N/A
1 country
1
Brief Summary
X-linked dystonia-parkinsonism (XDP) is a rare, X-linked, adult-onset, and progressive movement disorder seen almost exclusively in men from Panay Island in the Philippines. The disease is associated with mutations involving the DYT3/TAF1 gene, and all the cases described so far have been linked to Filipino ancestry. Although XDP is very rare globally, the prevalence is 5.74 per 100,000 individuals in Panay Island and 0.31 per 100,000 in the Philippines as a whole. Majority of patients (95%) were males, and the mean age of onset was 39 years. The mean duration of illness was 16 years, and the mean age of death was 55.6 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2022
CompletedFirst Posted
Study publicly available on registry
October 24, 2022
CompletedOctober 24, 2022
August 1, 2022
August 21, 2022
August 21, 2022
Conditions
Keywords
Interventions
XDP patients will receive unilateral or bilateral transcranial magnetic resonance-guided focused ultrasound pallidothalamic tractotomy.
Eligibility Criteria
You may qualify if:
- years old and above
- have been diagnosed with XDP and confirmed by genetic testing
- have a skull density ratio (SDR) of \>/= 0.35 on CT scan
- have psychiatric and medical clearance
- have passed the neurocognitive test
- have undergone MRgFUS pallidothalamic tractomy, either unilateral or bilateral,
You may not qualify if:
- patients aged less than 18 years old
- patients who have movement disorders other than XDP
- patients with abnormal neuroimaging findings that would preclude MRgFUS lesioning
- Skull SDR \< 0.35
- patients with medical contraindications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Philippine General Hospital
Manila, 1000, Philippines
Related Publications (1)
Jamora RDG, Khu KJO, Sy MCC, Pascual JSG, Legaspi GD, Aguilar JA. Transcranial magnetic resonance-guided focused ultrasound pallidothalamic tractotomy for patients with X-linked dystonia-parkinsonism: a study protocol. BMC Neurol. 2023 Aug 18;23(1):306. doi: 10.1186/s12883-023-03344-x.
PMID: 37596524DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Roland Dominic G Jamora, MD, PhD
Department of Neurosciences, University of the Philippines Manila
Central Study Contacts
Study Design
- Study Type
- expanded access
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 21, 2022
First Posted
October 24, 2022
Last Updated
October 24, 2022
Record last verified: 2022-08